IL18 and neoplasm: P2X7 activation by eATP also enhances anti-tumor effects through cGAMP transfer and STING activation, and the eATP–P2X7–inflammasome–IL18 axis reduces macrophage numbers in tumors while improving T-cell responses [76,77].